What are the clinical differences between stable angina and unstable angina and how should each be managed?

Stable vs Unstable Angina: Clinical Differences and Management

Unstable angina represents an acute coronary syndrome requiring immediate hospitalization and aggressive antiplatelet/anticoagulation therapy, while stable angina is a chronic condition managed with lifestyle modification and anti-anginal medications on an outpatient basis.

Clinical Differences

Stable Angina Characteristics 1

Stable angina presents with predictable, exertion-related chest discomfort that follows a consistent pattern:

• Substernal chest pressure/tightness lasting <10 minutes (typically 2-5 minutes)
• Provoked by exertion or emotional stress in a reproducible manner
• Relieved by rest and/or sublingual nitrates within minutes
• May radiate to jaw, teeth, shoulder blades, or arms
• Symptoms vary day-to-day but maintain a predictable threshold
• "Walk-through" or "warm-up" angina may occur (symptoms improve with continued exercise)

Unstable Angina Characteristics 2

Unstable angina is part of the acute coronary syndrome spectrum and presents with one or more of these features:

• New-onset angina (within 2 months) that is severe or frequent
• Crescendo pattern: previously stable angina that becomes more frequent, severe, or prolonged
• Angina at rest or with minimal exertion
• Prolonged duration (>10-20 minutes)
• May occur with dynamic ECG changes (ST-segment depression ≥0.5mm or T-wave inversion >1mm in ≥2 contiguous leads)
• Cardiac troponin remains negative (distinguishes from NSTEMI)

Pathophysiologic Distinction 2

The critical difference lies in the underlying mechanism:

• Stable angina: Fixed atherosclerotic stenosis causing supply-demand mismatch during exertion
• Unstable angina: Acute plaque rupture or erosion with partial coronary thrombosis and/or microemboli, causing diminished myocardial blood flow even at rest

Management Approach

Stable Angina Management 1

Outpatient medical optimization is the cornerstone:

Anti-anginal therapy:

• Beta-blockers as first-line for effort-related angina
• Calcium channel blockers for coronary vasospasm or when beta-blockers contraindicated
• Long-acting nitrates for additional symptom control
• Combination therapy may be synergistic 3

Prognostic medications (mandatory):

• Aspirin for all patients
• Statins regardless of cholesterol levels
• ACE inhibitors if hypertension, diabetes, or LV dysfunction present

Risk stratification:

• Non-invasive stress testing to assess ischemic burden
• Coronary angiography reserved for: severe ischemia on testing, symptoms refractory to medical therapy, or high-risk features

Unstable Angina Management 2

Immediate hospitalization with intensive monitoring is mandatory:

Acute phase (first 24-48 hours):

Antiplatelet therapy:

• Aspirin 162-325mg loading dose immediately 4
• Clopidogrel 300-600mg loading dose (pretreatment before angiography) 5, 4
• Consider GP IIb/IIIa inhibitors for high-risk patients or during PCI

Anticoagulation (choose one):

• Enoxaparin (preferred over UFH for ease of use, noninferior efficacy) 4
• Fondaparinux (alternative for conservative strategy or high bleeding risk) 4
• Bivalirudin (for invasive strategy, associated with less bleeding) 4
• Unfractionated heparin (if early invasive strategy planned within hours)

Anti-ischemic therapy:

• Sublingual/IV nitrates for symptom relief
• Beta-blockers (oral, avoid IV unless hypertensive)
• Calcium antagonists if symptoms persist despite above 6
• Oxygen only if hypoxemic
• Analgesia (morphine) for refractory pain

Invasive strategy selection 2, 5:

Early invasive approach (angiography within 24-48 hours) indicated for:

• Recurrent angina/ischemia at rest or low-level activity despite medical therapy
• Elevated troponin (even if initially negative, recheck)
• New or dynamic ST-segment or T-wave changes
• Hemodynamic instability
• High-risk features on non-invasive testing
• Prior PCI or CABG

Initial conservative approach (selective angiography only if recurrent symptoms):

• Low-risk patients who stabilize with medical therapy
• Significant comorbidities limiting revascularization benefit

Critical Pitfalls to Avoid

For stable angina:

• Don't perform routine coronary angiography without non-invasive risk stratification first 1
• Don't forget prognostic medications (aspirin, statins, ACE-I) - they reduce mortality more than symptom relief alone

For unstable angina:

• Never discharge from ED - this is ACS requiring admission 2
• Don't delay dual antiplatelet therapy while awaiting troponin results
• Don't use NSAIDs for chest pain (increases CV risk)
• Avoid abrupt beta-blocker withdrawal (may precipitate ACS)
• Recognize dynamic progression: patients can evolve from unstable angina to NSTEMI to STEMI rapidly 2

The fundamental management principle: stable angina is treated as an outpatient chronic condition focused on symptom control and risk factor modification, while unstable angina requires immediate hospitalization as an acute coronary syndrome with aggressive antithrombotic therapy and consideration for urgent revascularization.